Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
Measurement of the pressure or tension of liquids or gases with a manometer.
A hypermotility disorder of the ESOPHAGUS that is characterized by spastic non-peristaltic responses to SWALLOWING; CHEST PAIN; and DYSPHAGIA.
A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus).
The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
Pathological processes in the ESOPHAGUS.
The act of taking solids and liquids into the GASTROINTESTINAL TRACT through the mouth and throat.
The motor activity of the GASTROINTESTINAL TRACT.
Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. (Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415)
Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
Contraction of the muscle of the PHARYNX caused by stimulation of sensory receptors on the SOFT PALATE, by psychic stimuli, or systemically by drugs.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
c-Kit positive cells related to SMOOTH MUSCLE CELLS that are intercalated between the autonomic nerves and the effector smooth muscle cells of the GASTROINTESTINAL TRACT. Different phenotypic classes play roles as pacemakers, mediators of neural inputs, and mechanosensors.
Saccular protrusion beyond the wall of the ESOPHAGUS.
Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed)
A type of ILEUS, a functional not mechanical obstruction of the INTESTINES. This syndrome is caused by a large number of disorders involving the smooth muscles (MUSCLE, SMOOTH) or the NERVOUS SYSTEM.
Endoscopic examination, therapy or surgery of the esophagus.
Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
NATIONAL LIBRARY OF MEDICINE service for health professionals and consumers. It links extensive information from the National Institutes of Health and other reviewed sources of information on specific diseases and conditions.
An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
An epileptic syndrome characterized by the triad of infantile spasms, hypsarrhythmia, and arrest of psychomotor development at seizure onset. The majority present between 3-12 months of age, with spasms consisting of combinations of brief flexor or extensor movements of the head, trunk, and limbs. The condition is divided into two forms: cryptogenic (idiopathic) and symptomatic (secondary to a known disease process such as intrauterine infections; nervous system abnormalities; BRAIN DISEASES, METABOLIC, INBORN; prematurity; perinatal asphyxia; TUBEROUS SCLEROSIS; etc.). (From Menkes, Textbook of Child Neurology, 5th ed, pp744-8)

Altered oesophageal motility following the administration of the 5-HT1 agonist, sumatriptan. (1/117)

BACKGROUND: The 5-HT1 agonist sumatriptan, used in the treatment of migraine, can cause chest pain. AIM: To investigate the effect of a therapeutic dose of sumatriptan (6 mg s.c.) on oesophageal motility. METHODS: In 16 normal healthy subjects aged 19-32 years (9 males), the manometric response of the lower oesophageal sphincter (sleeve sensor), oesophageal body (four sites), stomach and pharynx (to register swallows) to 5 mL water swallows was assessed before and after a subcutaneous injection of either sumatriptan (6 mg) or saline control. Symptoms and ECGs were also monitored. RESULTS: Sumatriptan 6 mg s.c. altered oesophageal motility in all subjects. This was reflected by a significant increase in the amplitude of oesophageal body contractions (change from pre- to 1 h post-injection: sumatriptan 9.9 (2.8, 17.1) mmHg vs. placebo -0.8 (-4.2, 2.6) mmHg, difference 10.8 (4.4, 17.1) mmHg; P=0.003) and a transient increase in lower oesophageal sphincter pressure (change from pre- to 5 min post-injection: sumatriptan 10.9 (5.2, 16.6) mmHg vs. placebo 5.1 (1.8, 8.4) mmHg, difference 5.8 (-0.7, 12.3) mmHg; P=0.08). Sumatriptan had no effect on the velocity of propagation of oesophageal contractions (change from pre- to 1 h post-injection: sumatriptan -0.1 (-0.3, 0.1) cm/s vs. placebo -0.1 (-0.3, 0.0) cm/s, difference 0.1 (-0.1, 0.2) cm/s; P = 0.40). One subject experienced chest symptoms following sumatriptan and, although motility was altered, this did not reach pathological levels. No ECG abnormalities were observed. CONCLUSION: Sumatriptan (6 mg s.c.) significantly alters oesophageal motor function without affecting the ECG. It is therefore possible that sumatriptan-induced chest symptoms may have an oesophageal origin. The evaluation of similar therapeutic agents for migraine on oesophageal function may be justified.  (+info)

Functional esophageal disorders. (2/117)

The functional esophageal disorders include globus, rumination syndrome, and symptoms that typify esophageal diseases (chest pain, heartburn, and dysphagia). Factors responsible for symptom production are poorly understood. The criteria for diagnosis rest not only on compatible symptoms but also on exclusion of structural and metabolic disorders that might mimic the functional disorders. Additionally, a functional diagnosis is precluded by the presence of a pathology-based motor disorder or pathological reflux, defined by evidence of reflux esophagitis or abnormal acid exposure time during ambulatory esophageal pH monitoring. Management is largely empirical, although efficacy of psychopharmacological agents and psychological or behavioral approaches has been established for several of the functional esophageal disorders. As gastroesophageal reflux disease overlaps in presentation with most of these disorders and because symptoms are at least partially provoked by acid reflux events in many patients, antireflux therapy also plays an important role both in diagnosis and management. Further understanding of the fundamental mechanisms responsible for symptoms is a priority for future research efforts, as is the consideration of treatment outcome in a broader sense than reduction in esophageal symptoms alone. Likewise, the value of inclusive rather than restrictive diagnostic criteria that encompass other gastrointestinal and non-gastrointestinal symptoms should be examined to improve the accuracy of symptom-based criteria and reduce the dependence on objective testing.  (+info)

Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. (3/117)

BACKGROUND: Recent studies from our laboratory reveal that 70% of patients with gastro-oesophageal reflux disease (GERD) on proton pump inhibitors twice daily (b.d.) have nocturnal gastric acid breakthrough (gastric pH < 4 > 1 h) which is often accompanied by oesophageal acid exposure. The pathogenesis of GER during gastric acid breakthrough is not clear. AIM: To determine the prevalence of oesophageal motility abnormalities in patients with nocturnal GER associated with nocturnal acid breakthrough on proton pump inhibitor b.d. METHODS: We reviewed the pH-metry and manometric studies of 100 consecutive patients with GERD who were on proton pump inhibitor b.d. pH tracings were analysed for the nocturnal period (10.00 hours until 06.00 hours). Nocturnal GER was defined as> 0.5% time distal oesophageal pH < 4. Manometric tracings were reviewed for lower oesophageal sphincter (LES) pressure and oesophageal body motility. Chi-squared and Fischer's test were used for statistical analysis. RESULTS: Of the 100 patients, 74 (74%) had nocturnal gastric acid breakthrough. Thirty-one (42%) had concurrent abnormal nocturnal GER (refluxers) and 43 out of 74 (58%) had no GER (non-refluxers). The prevalence of ineffective oesophageal motility, and low LES pressure was significantly higher in refluxers than in non-refluxers (P < 0. 05, P < 0.001, respectively). Ineffective-oesophageal motility has a high specificity (91%), but low sensitivity (45%) as a diagnostic predictor for patients who are more likely to develop nocturnal GER on proton pump inhibitor b.d. CONCLUSION: Ineffective oesophageal motility is a risk factor for proton pump inhibitor refractory GER.  (+info)

Signal transduction in esophageal and LES circular muscle contraction. (4/117)

Contraction of normal esophageal circular muscle (ESO) in response to acetylcholine (ACh) is linked to M2 muscarinic receptors activating at least three intracellular phospholipases, i.e., phosphatidylcholine-specific phospholipase C (PC-PLC), phospholipase D (PLD), and the high molecular weight (85 kDa) cytosolic phospholipase A2 (cPLA2) to induce phosphatidylcholine (PC) metabolism, production of diacylglycerol (DAG) and arachidonic acid (AA), resulting in activation of a protein kinase C (PKC)-dependent pathway. In contrast, lower esophageal sphincter (LES) contraction induced by maximally effective doses of ACh is mediated by muscarinic M3 receptors, linked to pertussis toxin-insensitive GTP-binding proteins of the G(q/11) type. They activate phospholipase C, which hydrolyzes phosphatidylinositol bisphosphate (PIP2), producing inositol 1,4,5-trisphosphate (IP3) and DAG. IP3 causes release of intracellular Ca++ and formation of a Ca++-calmodulin complex, resulting in activation of myosin light chain kinase and contraction through a calmodulin-dependent pathway. Signal transduction pathways responsible for maintenance of LES tone are quite distinct from those activated during contraction in response to maximally effective doses of agonists (e.g., ACh). Resting LES tone is associated with activity of a low molecular weight (approximately 14 kDa) pancreatic-like (group 1) secreted phospholipase A2 (sPLA2) and production of arachidonic acid (AA), which is metabolized to prostaglandins and thromboxanes. These AA metabolites act on receptors linked to G-proteins to induce activation of PI- and PC-specific phospholipases, and production of second messengers. Resting LES tone is associated with submaximal PI hydrolysis resulting in submaximal levels of inositol trisphosphate (IP3-induced Ca++ release, and interaction with DAG to activate PKC. In an animal model of acute esophagitis, acid-induced inflammation alters the contractile pathway of ESO and LES. In LES circular muscle, after induction of experimental esophagitis, basal levels of PI hydrolysis are substantially reduced and intracellular Ca++ stores are functionally damaged, resulting in a reduction of resting tone. The reduction in intracellular Ca++ release causes a switch in the signal transduction pathway mediating contraction in response to ACh. In the normal LES, ACh causes release of Ca++ from intracellular stores and activation of a calmodulin-dependent pathway. After esophagitis, ACh-induced contraction depends on influx of extracellular Ca++, which is insufficient to activate calmodulin, and contraction is mediated by a PKC-dependent pathway. These changes are reproduced in normal LES cells by thapsigargin-induced depletion of Ca++ stores, suggesting that the amount of Ca++ available for release from intracellular stores defines the signal transduction pathway activated by a maximally effective dose of ACh.  (+info)

Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report. (5/117)

Transient esophageal motor dysfunction with dysphagia was observed in a 62-year-old man receiving vincristine-containing chemotherapy for non-Hodgkin's lymphoma. Neurological examinations, including muscle strength of extremities, deep tendon reflexes and cranial nerves, were normal. However, the patient complained of severe numbness in the fingertips and toes. The results of esophagogram and esophagoscopy were unremarkable. However, a significantly prolonged esophageal transit time was observed. Vincristine was considered as the causative agent. Empirical vitamin and metoclopramide were prescribed for his neurological symptoms but there was no improvement. The symptoms of dysphagia subsided spontaneously 2 weeks later. However, prompt recurrence of severe dysphagia was observed again after administration of the second and third courses of treatment, which again disappeared upon discontinuation of the drug. Peripheral nerves and the gastrointestinal tract are often affected by vincristine. Common gastrointestinal tract symptoms of vincristine neuropathy may be colicky abdominal pain and constipation. However, vincristine-induced esophageal motor dysfunction with dysphagia is uncommon but generally reversible. The oncologist and chemotherapist should be aware of this complication.  (+info)

Esophagitis-related esophageal shortening in opossum is associated with longitudinal muscle hyperresponsiveness. (6/117)

Acute intraluminal acid perfusion induces esophageal shortening in humans and opossums. Lower esophageal sphincter (LES) hypotension and peristaltic dysfunction occur in patients and animal models of reflux esophagitis. This study examined whether similar shortening and motor dysfunction occur in anesthetized opossums after repeated esophageal acid exposure and whether this is associated with longitudinal muscle (LM) hyperresponsiveness. Manometry used before and after 3 consecutive days of 45-min perfusion with 100 mmol/l HCl or normal saline measured esophageal length and motor responses to induced swallows. LM electrical and mechanical responses were assessed using standard isometric tension and intracellular recording techniques. Compared with controls, repeated acid perfusion induced erosive esophagitis and significant esophageal shortening, associated with enhanced LM responses to carbachol, a significantly depolarized resting membrane potential, and abnormal spike patterns. LES resting pressure and swallow-induced peristalsis were unaffected. In this model of reflux esophagitis, marked persistent esophageal shortening and associated LM hyperresponsiveness occur before significant LES or peristaltic dysfunction, suggesting that esophageal shortening is the earliest motor disorder induced by acid injury.  (+info)

Two cases of severe non-specific oesophageal dysmotility showing different response to botulinum injection therapy. (7/117)

We report 2 cases where treatment of achalasia type symptoms due to severe non-specific oesophageal dysmotility have shown symptom resolution and manometric improvement to intrasphincteric botulinum injections either by itself or in combination with oesophageal dilatation.  (+info)

Effect of graded running on esophageal motility and gastroesophageal reflux in fed volunteers. (8/117)

The effects of different grades of running on esophageal motility and gastroesophageal reflux in the fed state were evaluated. We studied healthy volunteers (male: 12, age: 27 +/- 5 yr) using ambulatory esophageal manometry, pH catheter and portable digital data recorder. Each exercise was performed 30 min after meal, with 20 min of rest between exercises. Subjects exercised on a treadmill at 40% and 70% maximal heart rate. The number of gastroesophageal reflux episodes, the duration of esophageal acid exposure and percent time pH below 4 were significantly (p < 0.01) increased during exercise at 70% maximal heart rate. The frequency of contraction (contraction/min) (p < 0.05), frequency of repetition (p < 0.01), percent of simultaneous contraction (p < 0.01), percent of above 100 mmHg amplitude (p < 0.05), and frequency of 2-peak contraction (p < 0.01) were significantly increased during exercise at 70% maximal heart rate. However, median amplitude and median duration showed no significant changes between each exercise session. Postprandial running exercises induce gastroesophageal reflux, which correlates with exercise intensity. These effects are mediated by disorganized esophageal motility.  (+info)

Esophageal motility disorders are a group of conditions that affect the normal movement (motility) of the muscles in the esophagus, which is the tube that connects the throat to the stomach. The esophageal muscles normally contract and relax in a coordinated manner to help move food from the mouth to the stomach.

In esophageal motility disorders, this muscle movement is impaired, leading to difficulty swallowing (dysphagia), chest pain, heartburn, or regurgitation of food. Some common examples of esophageal motility disorders include:

1. Achalasia: a condition in which the lower esophageal sphincter muscle fails to relax properly, preventing food from passing into the stomach.
2. Diffuse esophageal spasm: a disorder characterized by uncoordinated contractions of the esophageal muscles, leading to difficulty swallowing and chest pain.
3. Nutcracker esophagus: a condition in which the esophageal muscles contract too forcefully, causing pain and difficulty swallowing.
4. Hypertensive lower esophageal sphincter: a disorder in which the lower esophageal sphincter muscle is too tight, making it difficult to swallow and leading to symptoms such as heartburn and regurgitation.
5. Ineffective esophageal motility: a condition in which the esophageal muscles have weak or disorganized contractions, leading to difficulty swallowing and other symptoms.

Esophageal motility disorders can be diagnosed through tests such as manometry, which measures the pressure and coordination of esophageal muscle contractions, or barium swallow studies, which use X-rays to visualize the movement of food through the esophagus. Treatment may include medications, lifestyle changes, or surgery, depending on the specific disorder and its severity.

Manometry is a medical test that measures pressure inside various parts of the gastrointestinal tract. It is often used to help diagnose digestive disorders such as achalasia, gastroparesis, and irritable bowel syndrome. During the test, a thin, flexible tube called a manometer is inserted through the mouth or rectum and into the area being tested. The tube is connected to a machine that measures and records pressure readings. These readings can help doctors identify any abnormalities in muscle function or nerve reflexes within the digestive tract.

Diffuse Esophageal Spasm (DES) is a motility disorder of the esophagus, which is the muscular tube that connects the throat to the stomach. In DES, the esophagus involuntarily and uncoordinately contracts, causing difficulty swallowing (dysphagia), chest pain, and sometimes regurgitation of food or liquids.

The term "diffuse" refers to the fact that these spasms can occur throughout the entire length of the esophagus, rather than being localized to a specific area. The exact cause of diffuse esophageal spasm is not known, but it may be associated with abnormalities in the nerve cells that control muscle contractions in the esophagus.

Diagnosis of DES typically involves a combination of medical history, physical examination, and specialized tests such as esophageal manometry or ambulatory 24-hour pH monitoring. Treatment options may include medications to relax the esophageal muscles, lifestyle modifications such as avoiding trigger foods, and in some cases, surgery.

Esophageal achalasia is a rare disorder of the esophagus, the tube that carries food from the mouth to the stomach. In this condition, the muscles at the lower end of the esophagus fail to relax properly during swallowing, making it difficult for food and liquids to pass into the stomach. This results in symptoms such as difficulty swallowing (dysphagia), regurgitation of food, chest pain, and weight loss. The cause of esophageal achalasia is not fully understood, but it is believed to be related to damage to the nerves that control the muscles of the esophagus. Treatment options include medications to relax the lower esophageal sphincter, botulinum toxin injections, and surgical procedures such as laparoscopic Heller myotomy or peroral endoscopic myotomy (POEM).

The esophagus is the muscular tube that connects the throat (pharynx) to the stomach. It is located in the midline of the neck and chest, passing through the diaphragm to enter the abdomen and join the stomach. The main function of the esophagus is to transport food and liquids from the mouth to the stomach for digestion.

The esophagus has a few distinct parts: the upper esophageal sphincter (a ring of muscle that separates the esophagus from the throat), the middle esophagus, and the lower esophageal sphincter (another ring of muscle that separates the esophagus from the stomach). The lower esophageal sphincter relaxes to allow food and liquids to enter the stomach and then contracts to prevent stomach contents from flowing back into the esophagus.

The walls of the esophagus are made up of several layers, including mucosa (a moist tissue that lines the inside of the tube), submucosa (a layer of connective tissue), muscle (both voluntary and involuntary types), and adventitia (an outer layer of connective tissue).

Common conditions affecting the esophagus include gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, esophageal strictures, and eosinophilic esophagitis.

Peristalsis is an involuntary muscular movement that occurs in the digestive tract, including the esophagus, stomach, and intestines. It is characterized by alternate contraction and relaxation of the smooth muscles in the walls of these organs, which creates a wave-like motion that helps propel food, fluids, and waste through the digestive system.

The process of peristalsis begins with a narrowing or constriction of the muscle in one area of the digestive tract, followed by a relaxation of the muscle in the adjacent area. This creates a localized contraction that moves along the length of the organ, pushing its contents forward. The wave of contractions continues to move along the digestive tract until it reaches the anus, where waste is eliminated from the body.

Peristalsis plays a crucial role in maintaining proper digestion and absorption of nutrients, as well as in the elimination of waste products from the body. Disorders that affect peristalsis, such as gastrointestinal motility disorders, can lead to symptoms such as abdominal pain, bloating, constipation, or diarrhea.

Esophageal diseases refer to a range of medical conditions that affect the esophagus, which is the muscular tube that connects the throat to the stomach. Here are some common esophageal diseases with their brief definitions:

1. Gastroesophageal reflux disease (GERD): A chronic condition in which stomach acid or bile flows back into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.
2. Esophagitis: Inflammation of the esophageal lining, often caused by GERD, infection, or medication.
3. Esophageal stricture: Narrowing of the esophagus due to scarring or inflammation, which can make swallowing difficult.
4. Esophageal cancer: Cancer that forms in the tissues of the esophagus, often as a result of long-term GERD or smoking.
5. Esophageal motility disorders: Disorders that affect the normal movement and function of the esophagus, such as achalasia, diffuse spasm, and nutcracker esophagus.
6. Barrett's esophagus: A condition in which the lining of the lower esophagus changes, increasing the risk of esophageal cancer.
7. Esophageal diverticula: Small pouches that form in the esophageal wall, often causing difficulty swallowing or regurgitation.
8. Eosinophilic esophagitis (EoE): A chronic immune-mediated disorder characterized by inflammation of the esophagus due to an allergic reaction.

These are some of the common esophageal diseases, and their diagnosis and treatment may vary depending on the severity and underlying cause of the condition.

Deglutition is the medical term for swallowing. It refers to the process by which food or liquid is transferred from the mouth to the stomach through a series of coordinated muscle movements and neural responses. The deglutition process involves several stages, including oral preparatory, oral transit, pharyngeal, and esophageal phases, each of which plays a critical role in ensuring safe and efficient swallowing.

Dysphagia is the medical term for difficulty with swallowing, which can result from various underlying conditions such as neurological disorders, structural abnormalities, or muscular weakness. Proper evaluation and management of deglutition disorders are essential to prevent complications such as aspiration pneumonia, malnutrition, and dehydration.

Gastrointestinal motility refers to the coordinated muscular contractions and relaxations that propel food, digestive enzymes, and waste products through the gastrointestinal tract. This process involves the movement of food from the mouth through the esophagus into the stomach, where it is mixed with digestive enzymes and acids to break down food particles.

The contents are then emptied into the small intestine, where nutrients are absorbed, and the remaining waste products are moved into the large intestine for further absorption of water and electrolytes and eventual elimination through the rectum and anus.

Gastrointestinal motility is controlled by a complex interplay between the autonomic nervous system, hormones, and local reflexes. Abnormalities in gastrointestinal motility can lead to various symptoms such as bloating, abdominal pain, nausea, vomiting, diarrhea, or constipation.

Gastroesophageal reflux (GER) is the retrograde movement of stomach contents into the esophagus, which can cause discomfort and symptoms. It occurs when the lower esophageal sphincter (a ring of muscle between the esophagus and stomach) relaxes inappropriately, allowing the acidic or non-acidic gastric contents to flow back into the esophagus.

Gastroesophageal reflux becomes gastroesophageal reflux disease (GERD) when it is more severe, persistent, and/or results in complications such as esophagitis, strictures, or Barrett's esophagus. Common symptoms of GERD include heartburn, regurgitation, chest pain, difficulty swallowing, and chronic cough or hoarseness.

The lower esophageal sphincter (LES) is a specialized ring of muscle located at the junction of the esophagus and stomach. It functions as a physiological valve that regulates the direction of content flow between the esophagus and the stomach. Normally, the LES remains contracted to prevent the reflux of gastric contents into the esophagus, and it relaxes during swallowing to allow food to enter the stomach.

A dysfunctional lower esophageal sphincter may lead to gastroesophageal reflux disease (GERD), where stomach acid frequently backs up into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.

Esophageal pH monitoring is a medical test used to measure the acidity (pH level) inside the esophagus. The test involves inserting a thin, flexible tube through the nose and down into the esophagus. The tube contains a sensor that detects changes in pH levels and transmits this information to a recording device worn by the patient.

The test typically lasts for 24 hours, during which time the patient keeps a diary of their activities and symptoms. This information is used to correlate any symptoms with changes in pH levels. The test can help diagnose gastroesophageal reflux disease (GERD) and assess the effectiveness of treatment.

It's important to note that there are some precautions to be taken before and after the test, such as avoiding certain medications that may affect the pH levels or interfere with the test results. Patients should follow their healthcare provider's instructions carefully to ensure accurate results.

Deglutition disorders, also known as swallowing disorders, are conditions that affect the ability to move food or liquids from the mouth to the stomach safely and efficiently. These disorders can occur at any stage of the swallowing process, which includes oral preparation (chewing and manipulating food in the mouth), pharyngeal phase (activating muscles and structures in the throat to move food toward the esophagus), and esophageal phase (relaxing and contracting the esophagus to propel food into the stomach).

Symptoms of deglutition disorders may include coughing or choking during or after eating, difficulty initiating a swallow, food sticking in the throat or chest, regurgitation, unexplained weight loss, and aspiration (inhaling food or liquids into the lungs), which can lead to pneumonia.

Deglutition disorders can be caused by various factors, such as neurological conditions (e.g., stroke, Parkinson's disease, multiple sclerosis), structural abnormalities (e.g., narrowing or blockage of the esophagus), muscle weakness or dysfunction, and cognitive or behavioral issues. Treatment for deglutition disorders may involve dietary modifications, swallowing exercises, medications, or surgical interventions, depending on the underlying cause and severity of the condition.

"Gagging" is a reflexive response to an irritation or stimulation of the back of the throat, which involves involuntary contraction of the muscles at the back of the throat and sometimes accompanied by vomiting. It is a protective mechanism to prevent foreign objects from entering the lungs during swallowing. In a medical context, gagging may also refer to the use of a device or maneuver to temporarily block the upper airway as part of certain medical procedures.

The esophagogastric junction (EGJ) is the region of the gastrointestinal tract where the esophagus (the tube that carries food from the mouth to the stomach) meets the stomach. It serves as a physiological sphincter, which helps control the direction of flow and prevent reflux of gastric contents back into the esophagus. The EGJ is also known as the gastroesophageal junction or cardia.

Interstitial Cells of Cajal (ICCs) are specialized cells found in the walls of the gastrointestinal tract, as well as in other organs such as the urinary and vascular systems. They play a crucial role in regulating the motility of the digestive system by acting as pacemakers and mediators of nerve impulses that control muscle contractions. ICCs have a unique morphology, characterized by numerous extensions and a large number of mitochondria, which allow them to generate electrical signals and communicate with surrounding cells. They are named after Santiago Ramón y Cajal, the Spanish histologist who first described these cells in the late 19th century.

An esophageal diverticulum is a small pouch or sac that forms as a result of a protrusion or herniation of the inner lining (mucosa) of the esophagus through the outer layer of muscle in the wall of the esophagus. Esophageal diverticula can occur in any part of the esophagus, but they are most commonly found in the lower third of the esophagus, near the junction with the stomach.

Esophageal diverticula may be congenital (present at birth) or acquired (develop later in life). Acquired esophageal diverticula are often associated with underlying conditions such as esophageal motility disorders, strictures, or tumors that increase the pressure inside the esophagus and cause the mucosa to bulge out through weakened areas of the esophageal wall.

Symptoms of esophageal diverticula may include difficulty swallowing (dysphagia), regurgitation of undigested food, chest pain, heartburn, and recurrent respiratory infections due to aspiration of food or saliva into the lungs. Treatment options for esophageal diverticula depend on the size and location of the diverticulum, as well as the presence of any underlying conditions. Small asymptomatic diverticula may not require treatment, while larger symptomatic diverticula may be treated with surgical removal or endoscopic repair.

Fundoplication is a surgical procedure in which the upper part of the stomach (the fundus) is wrapped around the lower esophagus and then stitched into place. This procedure strengthens the lower esophageal sphincter, which helps prevent acid reflux from the stomach into the esophagus. It is commonly used to treat gastroesophageal reflux disease (GERD) and paraesophageal hernias.

Intestinal pseudo-obstruction, also known as paralytic ileus or functional obstruction, is a gastrointestinal motility disorder characterized by the absence of mechanical obstruction in the intestines, but with symptoms mimicking a mechanical small bowel obstruction. These symptoms may include abdominal distention, cramping, nausea, vomiting, and constipation or difficulty passing stools.

The condition is caused by impaired intestinal motility due to dysfunction of the nerves or muscles that control the movement of food and waste through the digestive system. It can be a chronic or acute condition and may occur as a primary disorder or secondary to other medical conditions, such as surgery, trauma, infections, metabolic disorders, neurological diseases, or certain medications.

Diagnosis of intestinal pseudo-obstruction typically involves imaging studies, such as X-rays or CT scans, to rule out mechanical obstruction and confirm the presence of dilated bowel loops. Manometry and other specialized tests may also be used to assess intestinal motility. Treatment options include medications to stimulate intestinal motility, dietary modifications, and in severe cases, surgery or intravenous nutrition.

Esophagoscopy is a medical procedure that involves the visual examination of the esophagus, which is the tube that connects the throat to the stomach. This procedure is typically carried out using an esophagogastroduodenoscope (EGD), a flexible tube with a camera and light on the end.

During the procedure, the EGD is inserted through the mouth and down the throat into the esophagus, allowing the medical professional to examine its lining for any abnormalities such as inflammation, ulcers, or tumors. The procedure may also involve taking tissue samples (biopsies) for further examination and testing.

Esophagoscopy is commonly used to diagnose and monitor conditions such as gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, and other disorders affecting the esophagus. It may also be used to treat certain conditions, such as removing polyps or foreign objects from the esophagus.

Gastroparesis is a gastrointestinal disorder that affects the stomach's normal motility, resulting in the delayed emptying of food from the stomach into the small intestine. The term "gastroparesis" literally means "stomach paralysis," although the stomach doesn't actually become paralyzed in this condition. Instead, the muscles of the stomach wall become weakened or damaged, leading to a decrease in their ability to contract and push food through the digestive tract effectively.

The causes of gastroparesis can vary, but some common reasons include diabetes (both type 1 and type 2), viral infections, surgery involving the vagus nerve (which controls stomach muscle contractions), certain medications (such as narcotics, antidepressants, and high blood pressure drugs), gastroesophageal reflux disease (GERD), scleroderma, Parkinson's disease, multiple sclerosis, and Amyloidosis.

Symptoms of gastroparesis may include nausea, vomiting, feeling full quickly after starting to eat, bloating, heartburn, abdominal pain, lack of appetite, and unintended weight loss. These symptoms can significantly impact a person's quality of life and make it difficult for them to maintain proper nutrition.

Diagnosis typically involves a thorough medical history, physical examination, and various tests such as upper endoscopy, gastric emptying studies (such as the scintigraphy scan), and manometry to assess stomach muscle function. Treatment options may include dietary modifications, medications to stimulate stomach contractions or reduce symptoms like nausea and vomiting, botulinum toxin injections, electrical stimulation of the stomach muscles, or, in severe cases, feeding tubes or surgery.

Gastrointestinal diseases refer to a group of conditions that affect the gastrointestinal (GI) tract, which includes the organs from the mouth to the anus, responsible for food digestion, absorption, and elimination of waste. These diseases can affect any part of the GI tract, causing various symptoms such as abdominal pain, bloating, diarrhea, constipation, nausea, vomiting, and weight loss.

Common gastrointestinal diseases include:

1. Gastroesophageal reflux disease (GERD) - a condition where stomach acid flows back into the esophagus, causing heartburn and other symptoms.
2. Peptic ulcers - sores that develop in the lining of the stomach or duodenum, often caused by bacterial infection or long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
3. Inflammatory bowel disease (IBD) - a group of chronic inflammatory conditions of the intestine, including Crohn's disease and ulcerative colitis.
4. Irritable bowel syndrome (IBS) - a functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits.
5. Celiac disease - an autoimmune disorder where the ingestion of gluten leads to damage in the small intestine.
6. Diverticular disease - a condition that affects the colon, causing diverticula (small pouches) to form and potentially become inflamed or infected.
7. Constipation - a common gastrointestinal symptom characterized by infrequent bowel movements, hard stools, and difficulty passing stools.
8. Diarrhea - a common gastrointestinal symptom characterized by loose, watery stools and frequent bowel movements.
9. Food intolerances and allergies - adverse reactions to specific foods or food components that can cause various gastrointestinal symptoms.
10. Gastrointestinal infections - caused by bacteria, viruses, parasites, or fungi that can lead to a range of symptoms, including diarrhea, vomiting, and abdominal pain.

CREST syndrome is a subtype of a autoimmune connective tissue disorder called scleroderma (systemic sclerosis). The name "CREST" is an acronym that stands for the following five features:

* Calcinosis: The formation of calcium deposits in the skin and underlying tissues, which can cause painful ulcers.
* Raynaud's phenomenon: A condition in which the blood vessels in the fingers and toes constrict in response to cold or stress, causing the digits to turn white or blue and become numb or painful.
* Esophageal dysmotility: Difficulty swallowing due to weakened muscles in the esophagus.
* Sclerodactyly: Thickening and tightening of the skin on the fingers.
* Telangiectasias: Dilated blood vessels near the surface of the skin, causing red spots or lines.

It's important to note that not everyone with CREST syndrome will have all five of these features, and some people may have additional symptoms not included in the acronym. Additionally, CREST syndrome is a chronic condition that can cause a range of complications, including lung fibrosis, kidney problems, and digital ulcers. Treatment typically focuses on managing specific symptoms and slowing the progression of the disease.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

MedlinePlus is not a medical term, but rather a consumer health website that provides high-quality, accurate, and reliable health information, written in easy-to-understand language. It is produced by the U.S. National Library of Medicine, the world's largest medical library, and is widely recognized as a trusted source of health information.

MedlinePlus offers information on various health topics, including conditions, diseases, tests, treatments, and wellness. It also provides access to drug information, medical dictionary, and encyclopedia, as well as links to clinical trials, medical news, and patient organizations. The website is available in both English and Spanish and can be accessed for free.

A spasm is a sudden, involuntary contraction or tightening of a muscle, group of muscles, or a hollow organ such as the ureter or bronchi. Spasms can occur as a result of various factors including muscle fatigue, injury, irritation, or abnormal nerve activity. They can cause pain and discomfort, and in some cases, interfere with normal bodily functions. For example, a spasm in the bronchi can cause difficulty breathing, while a spasm in the ureter can cause severe pain and may lead to a kidney stone blockage. The treatment for spasms depends on the underlying cause and may include medication, physical therapy, or lifestyle changes.

Infantile spasms, also known as West syndrome, is a rare but serious type of epilepsy that affects infants typically between 4-8 months of age. The spasms are characterized by sudden, brief, and frequent muscle jerks or contractions, often involving the neck, trunk, and arms. These spasms usually occur in clusters and may cause the infant to bend forward or stretch out. Infantile spasms can be a symptom of various underlying neurological conditions and are often associated with developmental delays and regression. Early recognition and treatment are crucial for improving outcomes.

  • Solid-and-liquid dysphagia is due to an esophageal motility disorder (or dysmotility) either in the upper esophagus (caused by, for example, myasthenia gravis, stroke, or dermatomyositis) or the lower esophagus (where causes include systemic sclerosis, CREST syndrome, or achalasia). (wikipedia.org)
  • Esophageal disease Esophageal motility study Esophageal spasm GERD Nutcracker esophagus Esophagogastric junction outflow obstruction Systemic sclerosis Esophageal food bolus obstruction Dysphagia Functional Lumen Imaging Probe Winterbauer RH (1964). (wikipedia.org)
  • Efficient transport by the esophagus requires a coordinated, sequential motility pattern that propels food from above and clears acid and bile reflux from below. (medscape.com)
  • Note the "bird-beak" appearance of the lower esophageal sphincter (LES), with a dilated, barium-filled esophagus proximal to it. (medscape.com)
  • An esophagram demonstrating the corkscrew esophagus picture observed in a patient with manometry confirmed findings of diffuse esophageal spasm (DES). (medscape.com)
  • The lower esophageal sphincter (LES) is composed entirely of smooth muscle and maintains a steady baseline tone to prevent gastric reflux into the esophagus. (medscape.com)
  • Overview of Esophageal and Swallowing Disorders The swallowing apparatus consists of the pharynx, upper esophageal (cricopharyngeal) sphincter, the body of the esophagus, and the lower esophageal sphincter (LES). (merckmanuals.com)
  • Further investigation may include an esophageal motility study, which is a procedure to assess the motor or muscle function of the esophagus. (usdigestivehealth.com)
  • Esophageal motility disorder, also known as esophageal dysmotility, is a medical condition characterised by the failure of the muscles in the esophagus to contract properly, resulting in an inadequate delivery of food and liquids into the stomach. (thegutclinicuk.com)
  • Esophageal motility disorders cause abnormalities in the contraction mechanism of the esophagus usually manifesting as non-cardiac chest pain or the sensation that food and/or liquids seem to get hung up in the chest after swallowing. (ohiogi.com)
  • The primary motility disorders are achalasia, diffuse esophageal spasm, nutcracker esophagus, and ineffective peristalsis. (ohiogi.com)
  • Participants will then learn a classification scheme for motility disorders of the esophagus, including functional obstruction, mechanical obstruction and hypomotility/dysmotility. (veteducation.com.au)
  • Esophageal spasms are abnormal contractions of the muscles in the esophagus, the tube that carries food from the mouth to the stomach. (medlineplus.gov)
  • POEM showed superior characteristics than the standard 100-year-old surgical or laparoscopic Heller myotomy (LHM), not only for all types of esophageal achalasia [classical (I), vigorous (II), spastic (III), Chicago Classification], but also for advanced sigmoid type achalasia (S1 and S2), failed LHM, or other esophageal motility disorders (diffuse esophageal spasm, nutcracker esophagus or Jackhammer esophagus). (wjgnet.com)
  • The team at the Cooper Digestive Health Institute provides the latest diagnostic procedures and treatment options for patients with disorders of the pancreas, liver, gallbladder, esophagus, stomach, small intestine and colon. (cooperhealth.org)
  • 2,3,4 By quantifying the contractions of the esophagus and its sphincters, this procedure helps you get a more complete esophageal pressure profile of your patients. (medtronic.com)
  • Other complications of long standing GERD or H.pylori infection like esophageal cancer or Barrett's esophagus may also be responsible. (healthhype.com)
  • Failure of the lower esophageal sphincter (LES) to relax causes food to accumulate in the esophagus (gullet). (healthhype.com)
  • Once this oropharyngeal phase has served to propel the bolus into the esophagus, the esophageal phase of deglutition takes over. (nature.com)
  • A number of methodologies have been used to study motility of the esophagus. (nature.com)
  • Functional GI and motility disorders which affect the upper GI tract from the esophagus to the stomach. (iffgd.org)
  • Esophageal symptoms may consist of heartburn, regurgitation, dysphagia (the sensation that food is not traveling through the esophagus), chest pain, or even food impaction. (iffgd.org)
  • In this presentation, Dr. John Pandolfino discusses the providers' approach to diagnose and treat a patient living with a disorder of the throat and esophagus. (iffgd.org)
  • Patients with esophageal motility disorders are then treated, for example in achalasia, they may undergo pneumatic endoscopic balloon dilation, BoTox injection, or be referred to a surgeon, as appropriate for each individual circumstance based on detailed consultation. (ohiogi.com)
  • Peroral endoscopic myotomy (POEM) is an innovative, minimally invasive, endoscopic treatment for esophageal achalasia and other esophageal motility disorders, emerged from the natural orifice transluminal endoscopic surgery procedures, and since the first human case performed by Inoue in 2008, showed exciting results in international level, with more than 4000 cases globally up to now. (wjgnet.com)
  • METHODS/BACKGROUND: Achalasia is an esophageal motility disorder characterized by dysphagia, regurgitation, reflux, recurrent vomiting, and weight loss. (jefferson.edu)
  • POEM is a novel endoscopic procedure which involves cutting the lower esophageal sphincter to allow food to pass, and is considered a safe and effective management option for achalasia in non-pregnant individuals. (jefferson.edu)
  • citation needed] Solid dysphagia is due to obstructions such as esophageal cancer, esophageal webs, or stricture. (wikipedia.org)
  • can affect swallowing but are not typically classified as esophageal motility disorders because they largely cause oropharyngeal dysphagia and not esophageal dysphagia. (merckmanuals.com)
  • Symptoms of esophageal motility disorders depend on the cause but typically include difficulty swallowing (dysphagia), chest pain, and/or heartburn. (merckmanuals.com)
  • His clinical interests are dysphagia, esophageal disorders, motility disorders and functional gastrointestinal disorders, including irritable bowel syndrome. (iuhealth.org)
  • He currently is funded by the NIH to study GERD and Dysphagia pathogenesis and also receives funding from industry focused on the development of new technologies to investigate and treat gastrointestinal disorders. (iffgd.org)
  • Testing to diagnose EMD includes barium esophagography, upper endoscopy, and esophageal manometry. (wikipedia.org)
  • Esophageal function is usually assessed with motility testing, also called manometry. (ohiogi.com)
  • Diagnostic yield of 24-hour esophageal manometry in non-cardiac chest pain. (medscape.com)
  • High-resolution manometry in clinical practice: utilizing pressure topography to classify oesophageal motility abnormalities. (medscape.com)
  • View the guide for instructions to clean esophageal portfolio products, including ManoScan™ ESO high resolution manometry system. (medtronic.com)
  • Our lab features the latest esophageal reflux monitoring and high-resolution esophageal and anorectal manometry. (henryford.com)
  • Manometry (or motility study) is a test that measures how well muscles in your digestive tract work. (henryford.com)
  • We use esophageal manometry to evaluate swallowing problems. (henryford.com)
  • Almansa C, Hinder RA, Smith CD, Achem SR. A comprehensive appraisal of the surgical treatment of diffuse esophageal spasm. (medscape.com)
  • Almansa C, Achem SR. [Diffuse esophageal spasm (DES). (medscape.com)
  • Managing diffuse oesophageal spasm. (medscape.com)
  • Nino-Murcia M, Stark P, Triadafilopoulos G. Esophageal wall thickening: a CT finding in diffuse esophageal spasm. (medscape.com)
  • CHARLOTTESVILLE, Va. (WVIR) - There's a new study out of the University of Virginia School of Medicine and the College and Graduate School of Arts & Sciences that could lead to new treatments for swallowing disorders. (whsv.com)
  • His career has focused primarily on studying the biomechanics of bolus transport and gastrointestinal motility as it pertains to gastroesophageal reflux and swallowing disorders. (iffgd.org)
  • An esophageal motility disorder (EMD) is any medical disorder causing difficulty in swallowing, regurgitation of food and a spasm-type pain which can be brought on by an allergic reaction to certain foods. (wikipedia.org)
  • The cause of esophageal spasm is unknown. (medlineplus.gov)
  • Nitroglycerin given under the tongue (sublingual) may help a sudden episode of esophageal spasm. (medlineplus.gov)
  • An esophageal spasm may come and go (intermittent) or last for a long time ( chronic) . (medlineplus.gov)
  • Contact your health care provider if you have symptoms of esophageal spasm that don't go away. (medlineplus.gov)
  • The differential diagnosis for these common esophageal symptoms is vast and could be Gastroesophageal Reflux Disease (GERD) , Eosinophilic Esophagitis (EoE) , Obstruction, Motility Disorder, or Functional Esophageal Disorder. (iffgd.org)
  • A recognized national authority on esophageal disease, Dr. Katz's research interests include all aspects of gastroesophageal reflux disease, esophageal motility disorders and esophageal pain perception. (gi.org)
  • Our resources include the latest advances in the diagnosis and treatment of gastrointestinal disorders, including minimally invasive endoscopic equipment. (cooperhealth.org)
  • The upper esophageal sphincter (UES) is comprised of several striated muscles, creating a tonically closed valve and preventing air from entering into the gastrointestinal tract. (medscape.com)
  • The upper esophageal sphincter ( UES ) and proximal one third of esophageal body is composed of striated muscle. (nature.com)
  • 12 Spechler S J, Castell D O. Classification of oesophageal motility abnormalities. (thieme-connect.de)
  • Esophageal motility disorders are diseases caused by abnormal esophageal muscle function. (usdigestivehealth.com)
  • Carol Reinero specializes in small animal internal medicine with special interests in respiratory medicine and a particular focus on lower airway disorders and interstitial lung diseases. (veteducation.com.au)
  • Special testing and treatments for complex gastrointestinal conditions, such as esophageal motility disorders and inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. (va.gov)
  • HHV-4, also known as Epstein-Barr virus (EBV), causes the primary infection infectious mononucleosis , and it is implicated in various diseases, such as African Burkitt lymphoma , other immunoproliferative disorders, and nasopharyngeal carcinoma. (medscape.com)
  • He also maintains a strong clinical practice and in the Esophageal Center at Northwestern which serves as one of the nation's top referral centers for complicated esophageal diseases. (iffgd.org)
  • Among survivors of COVID-19, investigators identified an increase in such diagnoses as esophageal diseases, abdominal pain, diarrhea, and irritable bowel syndrome , as well as increased use of laxatives , histamine receptor antagonists, and acid-suppressive medicines. (medscape.com)
  • Many patients are well aware that it is a warning of potential life-threatening disorders and seek evaluation for minimal symptoms. (merckmanuals.com)
  • What are the symptoms of esophageal motility disorder? (thegutclinicuk.com)
  • A positive test shows that your symptoms are caused by esophageal reflux of acid from the stomach. (ucsfhealth.org)
  • Esophageal symptoms and selection of diagnostic tests. (ucsfhealth.org)
  • If you have a GI motility disorder such as acid reflux or irritable bowel syndrome, you've likely spent months or years trying to understand what's causing your symptoms. (henryford.com)
  • Regardless of how a patient's esophageal symptoms may present, all symptoms lead to an endoscopy (a nonsurgical procedure that uses a flexible tube with a light and camera to examine a person's digestive tract). (iffgd.org)
  • This may also play out with other symptoms, as noted in a recent paper highlighting the effect on serotonin-driven mood and motility . (medscape.com)
  • We're also one of only a few providers in Michigan to offer EndoFLIP®, the newest minimally invasive test for esophageal motility disorders. (henryford.com)
  • This will be followed by a discussion of the diagnostic approach to identify the underlying cause of the esophageal motility disorder, highlighting a critical role for videofluoroscopic swallow studies for both diagnosis and management. (veteducation.com.au)
  • Herbella FA, Raz DJ, Nipomnick I, Patti MG. Primary versus secondary esophageal motility disorders: diagnosis and implications for treatment. (medscape.com)
  • GI motility disorder diagnosis: Why choose Henry Ford? (henryford.com)
  • Disorders of esophageal motility are referred to as primary or secondary esophageal motility disorders and categorized according to their abnormal manometric patterns. (medscape.com)
  • Patients with symptomatic gastrooesophageal reflux tended to have abnormal acid clearance, as did those with oesophageal motility disorders. (bmj.com)
  • We conclude that abnormal acid clearing may result from disturbed oesophageal motility and render patients with these disorders susceptible to reflux oesophagitis. (bmj.com)
  • However, it also seems that gastrooesophageal reflux may lead to impaired acid clearance, both by creating abnormal motility and by effects on the oesophageal wall, and thus lead to a `vicious-spiral' oesophagitis. (bmj.com)
  • Esophageal neuromuscular function and motility disorders. (medlineplus.gov)
  • When I was a fellow and trainee at Northwestern University, some of the best research focused on gastrointestinal motility and physiology. (medlineplus.gov)
  • Esophageal motility disorder may be a result of CREST syndrome, referring to the five main features: calcinosis, Raynaud syndrome, esophageal dysmotility, sclerodactyly and telangiectasia. (wikipedia.org)
  • If there is a food allergy causing the dysmotility disorder, then physicians recommend an elimination diet. (wikipedia.org)
  • The coordination of these simultaneously contracting muscle layers produces the motility pattern known as peristalsis. (medscape.com)
  • Esophageal peristalsis results from sequential contraction of circular muscle, which serves to push the ingested food bolus toward the stomach. (nature.com)
  • Esophageal longitudinal muscle may also play a role in peristalsis. (nature.com)
  • Swallow-induced peristalsis is called primary peristalsis, and the peristalsis elicited by esophageal distention is called secondary peristalsis. (nature.com)
  • Esophageal peristalsis can be initiated by deglutition ("primary" peristalsis) or local distention ("secondary" peristalsis). (nature.com)
  • This review focuses on the physiologic mechanisms underlying peristalsis in the esophageal body. (nature.com)
  • Motility testing helps your gastroenterologist find out if you have a problem with the nerves and muscles in your digestive tract. (henryford.com)
  • Motility is a term used to describe the contraction of the muscles that mix and propel contents in the gastrointestinal (GI) tract. (iffgd.org)
  • Other esophageal motility disorders may also be responsible for chest pain during and after meals. (healthhype.com)
  • What are the treatments for esophageal motility disorder? (thegutclinicuk.com)
  • The program will finish with a description of dietary interventions and other ancillary treatments to address esophageal motility disorders. (veteducation.com.au)
  • The lower esophageal sphincter ( LES ) and the distal one half to two thirds of the esophageal body are composed of smooth muscle. (nature.com)
  • The response to amyl nitrate (a smooth muscle relaxant), with partial relaxation of the lower esophageal sphincter (LES), allows some barium to pass through it into the stomach. (medscape.com)
  • Furthermore, biliary pain may be associated with functional disorders of the biliary tract, so-called acalculous biliary pain (pain without stones), and can even be found in patients post-cholecystectomy (removal of the gallbladder), possibly as a consequence of dysfunction of the biliary tree and the sphincter of Oddi . (wikipedia.org)
  • 5 Katz P O. Intragastric and oesophageal pH monitoring in patients with gastro-oesophageal reflux disease. (thieme-connect.de)
  • Our comprehensive solutions can assist you in the assessment and treatment of esophageal patients. (medtronic.com)
  • Sur 220 patients admis dans l'unité de soins intensifs en chirurgie, auxquels une sonde nasogastrique avait été posée pendant plus de 24 heures, 68 cas se sont vu administrer du métoclopramide par voie orale (10 mg toutes les 8 heures) et 152 patients témoins n'ont rien reçu. (who.int)
  • Discussions of irritable bowel syndrome inevitably give rise to those around functional bowel and functional dyspepsia, as well as the brain-gut axis and how it relates to some of the anxiety, depression , and other mental health disorders that can occur in patients with functional bowel disease. (medscape.com)
  • Esophageal motility disorders in terms of pressure topography: the Chicago Classification. (medscape.com)
  • This occurs through sequential or "peristaltic" contraction of circular muscle in the esophageal body, in concert with appropriately timed relaxation of the upper and lower esophageal sphincters. (nature.com)
  • Esophageal motility disorder is an umbrella term for various disorders that make swallowing and getting food to your stomach difficult. (thegutclinicuk.com)
  • This involves two major phenomena, namely the sequential contraction of circular muscle of the esophageal body, which results in a peristaltic wave that pushes the food toward the stomach, and relaxation and opening of the LES . (nature.com)
  • Our Center for Motility Disorders is known throughout Michigan and the Midwest for its diagnostic expertise. (henryford.com)
  • Gastroenterologists , GI motility nurses, pathologists and radiologists work together to streamline the diagnostic process, so we can build a treatment plan sooner. (henryford.com)
  • EndoFLIP (endoluminal functional lumen imaging probe) is the latest diagnostic test to measure esophageal function. (henryford.com)
  • Systemic lupus erythematosus (SLE) is a chronic autoimmune connective tissue disorder, with a heterogeneous presentation. (lww.com)
  • The disorder was recognized as early as the Middle Ages, with the 12th-century physician Rogerius being the first to apply the term lupus to the classic malar rash, and in 1872, Moric Kaposi first recognized the systemic nature of the disease. (lww.com)
  • Clinical characteristics associated with esophageal motility function. (medscape.com)
  • Treatment options include dietary modification and medications which promote appropriate esophageal muscle function. (usdigestivehealth.com)
  • In addition, esophageal wall thickness can be evaluated and assessed as to its role in esophageal function. (elsevierpure.com)
  • 8 Vaezi M F. Oesophageal function testing - the old and the new. (thieme-connect.de)
  • A physiological model for the investigation of esophageal motility in healthy and pathologic conditions. (medscape.com)
  • Many other disorders can affect the digestive tract, with uniquely identifying features which differentiate them from functional GI or motility disorders. (iffgd.org)
  • Avoid very hot or very cold foods if you get esophageal spasms. (medlineplus.gov)
  • Acid clearance correlated well with the mean duration of spontaneous episodes of acid reflux during 15-hour continuous recordings of lower oesophageal pH. (bmj.com)
  • This procedure allows measurements of esophageal distensibility. (merckmanuals.com)
  • Parkinson's disease (PD) is a progressive neurodegenerative disorder characterised by motor dysfunction (parkinsonism) and several non-motor features. (bmj.com)
  • Detection of autonomic dysfunction may therefore be helpful in diagnosing PD in the early or pre-motor stages, and/or in differentiating it from other parkinsonian disorders, such as multiple system atrophy and progressive supuranuclear palsy. (bmj.com)
  • Cardiovascular disorders, malignant tumors, and erectile dysfunction are common complications of smoking in the Egyptian population. (who.int)
  • We've identified these neurons, so we can get access to the neural circuits that control swallowing and we can understand how they work and maybe how they don't work in cases of disease and disorders," Campbell said. (whsv.com)
  • Oesophageal acid clearing has been measured by counting the number of swallows needed to raise the lower oesophageal pH from 1·5 to 5·0 after instilling 15 ml 0·1 N hydrochloric acid. (bmj.com)
  • Functional GI and motility disorders which affect the lower GI tract from the small intestine/bowel, to the large intestine/bowel or colon, to the rectum. (iffgd.org)

No images available that match "esophageal motility disorders"